Targeted child psychiatric services: A new model of pediatric primary clinician - Child psychiatry collaborative care

Clinical Pediatrics

Volumn 45, Issue 5, 2006, Pages 423-434

  Connor, Daniel F ^a,b   McLaughlin, Thomas J ^a   Jeffers Terry, Mary ^a   O'Brien, William H ^a   Stille, Christopher J ^a   Young, Lynda M ^a   Antonelli, Richard C ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; ATOMOXETINE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CHLORPROMAZINE; CLONIDINE; GUANFACINE; HALOPERIDOL; HYDRAZINE; LITHIUM; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIORIDAZINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ADOLESCENT; ANXIETY DISORDER; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD BEHAVIOR; CHILD PSYCHIATRY; COMORBIDITY; DEPRESSION; FEMALE; FUNCTIONAL DISEASE; HEALTH CARE ACCESS; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PEDIATRICS; PSYCHOPHARMACOLOGY;

ADOLESCENT; CHILD; CHILD PSYCHIATRY; HUMANS; INTERPROFESSIONAL RELATIONS; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PRIMARY HEALTH CARE; PROGRAM EVALUATION; REGRESSION ANALYSIS; RESEARCH DESIGN;

EID: 33747495308     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/0009922806289617     Document Type: Article

References (46)

1. Costello EJ, Mustillo S, Erkanli A, et al. Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry. 2003;60(8):837-844.
2. Costello EJ, Angold A, Burns BJ, et al. The Great Smoky Mountains Study of Youth. Goals, design, methods, and the prevalence of DSM-III-R disorders. Arch Gen Psychiatry. 1996;53 (12):1129-1136.
3. Costello EJ. Child psychiatric disorders and their correlates: a primary care pediatric sample. J Am Acad Child Adolesc Psychiatry. 1989;28(6):851-855.
4. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med. 2002;156(6):592-598.
5. Williams J, Klinepeter K, Palmes G, et al. Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics. 2004;114(3):601-606.
6. Kelleher KJ, McInerny TK, Gardner WP, et al. Increasing identification of psychosocial problems: 1979-1996. Pediatrics. 2000;105(6):1313-1321.
7. Cartwright-Hatton S, Roberts C, Chitsabesan P, et al. Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. Br J Clin Psychol. 2004;43(Pt 4):421-436.
8. Reinecke MA, Ryan NE, DuBois DL. Cognitive-behavioral therapy of depression and depressive symptoms during adolescence: a review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 1998;37(1):26-34.
9. Fonagy P. Evaluating the effectiveness of interventions in child psychiatry. Can J Psychiatry. 1997;42(6):584-594.
10. Pappadopulos EA, Tate Guelzow B, Wong C, et al. A review of the growing evidence base for pediatric psychopharmacology. Child Adolesc Psychiatr Clin N Am. 2004;13(4):817-855.
11. Riddle MA, Kastelic EA, Frosch E. Pediatric psychopharmacology. J Child Psychol Psychiatry. 2001;42(1):73-90.
12. Bernal P. Hidden morbidity in pediatric primary care. Pediatr Ann. 2003;32(6):413-418; quiz 421-422.
13. Cassidy LJ, Jellinek MS. Approaches to recognition and management of childhood psychiatric disorders in pediatric primary care. Pediatr Clin North Am. 1998;45(5):1037-1052.
14. Rushton JL, Whitmire JT. Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. Arch Pediatr Adolesc Med. 2001;155(5):560-565.
15. Rushton JL, Clark SJ, Freed GL. Pediatrician and family physician prescription of selective serotonin reuptake inhibitors. Pediatrics. 2000;105(6):E82.
16. American Academy of Pediatrics. The new morbidity revisited: a renewed commitment to the psychosocial aspects of pediatric care. Committee on Psychosocial Aspects of Child and Family Health. Pediatrics. 2001;108 (5):1227-1230.
17. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Measur. 1960;20:37-46.
18. APA. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press; 1994.
19. Jellinek MS, Murphy JM, Robinson J, et al. Pediatric Symptom Checklist: screening school-age children for psychosocial dysfunction. J Pediatr. 1988;112(2):201-209.
20. Jellinek MS, Murphy JM, Little M, et al. Use of the Pediatric Symptom Checklist to screen for psychosocial problems in pediatric primary care: a national feasibility study. Arch Pediatr Adolesc Med. 1999;153(3):254-260.
21. Achenbach TM. Child Behavior Checklist - Cross-Informant Version. Burlington, VT: Department of Psychiatry, University of Vermont; 1991.
22. Jellinek MS, Murphy JM, Burns BJ. Brief psychosocial screening in outpatient pediatric practice. J Pediatr. 1986;109(2):371-378.
23. Jellinek M, Little M, Murphy JM, et al. The Pediatric Symptom Checklist. Support for a role in a managed care environment. Arch Pediatr Adolesc Med. 1995;149(7):740-746.
24. Jellinek MS, Bishop SJ, Murphy JM, et al. Screening for dysfunction in the children of outpatients at a psychopharmacology clinic. Am J Psychiatry. 1991;148(8):1031-1036.
25. Conners CK. Manual For Conners' Rating Scales. North Tonawanda, NY: Multi-Health Systems, Inc.; 1990.
26. Guy W. Assessment Manual for Psychopharmacology. Washington, DC: U.S. Department of Health, Education, and Welfare; 1976.
27. Shaffer D, Gould MS, Brasic J, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228-1231.
28. Rey JM, Starling J, Wever C, et al. Inter-rater reliability of global assessment of functioning in a clinical setting. J Child Psychol Psychiatry. 1995;36(5):787-792.
29. Lavigne JV, Gibbons RD, Christoffel KK, et al. Prevalence rates and correlates of psychiatric disorders among preschool children. J Am Acad Child Adolesc Psychiatry. 1996;35(2):204-214.
30. Hosmer D, Lemeshow S. Applied Logistic Regression. New York: John Wiley; 1989.
31. Costello EJ, Edelbrock C, Costello AJ, et al. Psychopathology in pediatric primary care: the new hidden morbidity. Pediatrics. 1988;82(3 Pt 2):415-424.
32. Briggs-Gowan MJ, Owens PL, Schwab-Stone ME, et al. Persistence of psychiatric disorders in pediatric settings. J Am Acad Child Adolesc Psychiatry. 2003;42(11):1360-1369.
33. Briggs-Gowan MJ, Horwitz SM, Schwab-Stone ME, et al. Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry. 2000;39(7):841-849.
34. Skaer TL, Sclar DA, Robison LM. Antidepressant trends among children and adolescents diagnosed with depression: 1990-2001. In: National Institute of Mental Health New Clinical Drug Evaluation Unit Annual Meeting; 2004; Phoenix, Arizona; 2004.
35. Olson AL, Kelleher KJ, Kemper KJ, et al. Primary care pediatricians' roles and perceived responsibilities in the identification and management of depression in children and adolescents. Ambul Pediatr. 2001;1(2):91-98.
36. Rushton JL, Clark SJ, Freed GL. Primary care role in the management of childhood depression: a comparison of pediatricians and family physicians. Pediatrics. 2000;105(4 Pt 2):957-962.
37. American Academy of Pediatrics. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033-1044.
38. American Academy of Pediatrics. Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. American Academy of Pediatrics. Pediatrics. 2000;105(5):1158-1170.
39. Biederman J, Newcorn J, Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry. 1991;148(5):564-577.
40. Barkley RA. Attention-deficit hyperactivity disorder. Sci Am. 1998; 279 (3):66-71.
41. Pliszka SR. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management. Paediatr Drugs. 2003;5(11):741-750.
42. Pliszka SR. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry. 1998;59(Suppl 7):50-58.
43. Connor DF. Aggression and Antisocial Behavior in Children and Adolescents: Research and Treatment. New York: Guilford Publications; 2002.
44. Steiner H. Practice parameters for the assessment and treatment of children and adolescents with conduct disorder. American Academy of Child and Adolescent Psychiatry. J Am Acad Child Adolesc Psychiatry. 1997;36(10 Suppl):122S-139S.
45. Bird HR, Gould MS, Staghezza BM. Patterns of diagnostic comorbidity in a community sample of children aged 9 through 16 years. J Am Acad Child Adolesc Psychiatry. 1993;32(2):361-368.
46. Biederman J, Faraone SV, Monuteaux MC. Differential effect of environmental adversity by gender: Rutter's index of adversity in a group of boys and girls with and without ADHD. Am J Psychiatry. 2002;159(9):1556-1562.